Circassia takes on full US rights to AZ’ Tudorza

12th December 2018 Uncategorised 0

Circassia Pharmaceuticals is exercising an option to acquire the full US commercial rights to AstraZeneca’s Tudorza.

More: Circassia takes on full US rights to AZ’ Tudorza
Source: News